Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1827462 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL1985823 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2176899 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2177991 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2174526 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL132521 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2173439 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL536857 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL443449 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL294141 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2946795-B1 | TISSUE ADHESIVE AND PROCESS FOR PRODUCING SAME | NAT INST MATERIALS SCIENCE (JP) | 2019-04-17 | — | — | EP | claimed |
| US-10064973-B2 | Tissue adhesive and method for producing same | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2018-09-04 | — | — | US | claimed |
| US-20150359924-A1 | TISSUE ADHESIVE AND METHOD FOR PRODUCING SAME | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2015-12-17 | — | — | US | claimed |
| EP-2946795-A1 | TISSUE ADHESIVE AND PROCESS FOR PRODUCING SAME | National Institute for Materials Science (JP) | 2015-11-25 | — | — | EP | claimed |
| US-4785012-A | OXAZOLE DERIVATIVES CONTAINING ALCOHOLS OR ESTERS | SYNTEX CORPORATION (US) | 1988-11-15 | — | — | US | claimed |
| WO-2024014310-A1 | COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND | L'OREAL (FR) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024014311-A1 | COSMETIC COMPOSITION COMPRISING SELECTED OIL AND DIOL | L'OREAL (FR) | 2024-01-18 | — | — | WO | disclosed |
| US-10670997-B2 | Intermediate transfer body, method for manufacturing intermediate transfer body, and image forming device | Konica Minolta, Inc. (JP) | 2020-06-02 | — | — | US | disclosed |
| US-20200081376-A1 | INTERMEDIATE TRANSFER BODY, METHOD FOR MANUFACTURING INTERMEDIATE TRANSFER BODY, AND IMAGE FORMING DEVICE | Konica Minolta, Inc. (JP) | 2020-03-12 | — | — | US | disclosed |
| EP-2946795-B1 | TISSUE ADHESIVE AND PROCESS FOR PRODUCING SAME | NAT INST MATERIALS SCIENCE (JP) | 2019-04-17 | — | — | EP | disclosed |
| US-10064973-B2 | Tissue adhesive and method for producing same | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2018-09-04 | — | — | US | disclosed |
| US-20150359924-A1 | TISSUE ADHESIVE AND METHOD FOR PRODUCING SAME | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2015-12-17 | — | — | US | disclosed |
| EP-2946795-A1 | TISSUE ADHESIVE AND PROCESS FOR PRODUCING SAME | National Institute for Materials Science (JP) | 2015-11-25 | — | — | EP | disclosed |
| US-7973145-B2 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | TOYO SUISAN KAISHA, LTD. (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20100298246-A1 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | TOYO SUISAN KAISHA, LTD. (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20090209475-A1 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | TOYO SUISAN KAISHA, LTD. (JP) | 2009-08-20 | — | — | US | disclosed |
| WO-2005014528-A1 | STRAIGHT-CHAIN AND BRANCHED-CHAIN LIPID COMPOUNDS AS SELECTIVE INHIBITORS OF CYCLOOXYGENASE-2, ANTI-INFLAMMATORY AGENTS, AND ANTI-CANCER AGENTS | YANG ZHENHUA (US) | 2005-02-17 | — | — | WO | disclosed |
| US-4785012-A | OXAZOLE DERIVATIVES CONTAINING ALCOHOLS OR ESTERS | SYNTEX CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298246-A1 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | SLC5A2, SLC5A1, DEGS1 | LMNA 3304/4885KDM4C 2335/4885TRPV1 1543/4885 |
| US-20090209475-A1 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | SLC5A2, SLC5A1, DEGS1 | LMNA 3304/4885KDM4C 2335/4885TRPV1 1543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.